Mesdopetam - Integrative Research Laboratories
Alternative Names: IRL-790Latest Information Update: 17 Jul 2024
At a glance
- Originator Integrative Research Laboratories
- Developer Integrative Research Laboratories; Ipsen
- Class Amines; Antiparkinsonians; Antipsychotics; Fluorobenzenes; Phenyl ethers; Small molecules; Sulfones
- Mechanism of Action Dopamine D3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase II/III Parkinson's disease
- Phase I Drug-induced dyskinesia
- Preclinical Psychotic disorders